Fitch Even Partner Ken Colton Quoted in ACS Chemical & Engineering News
May 21, 2014Fitch Even partner Kendrew H. Colton was quoted in an article published online on May 21, 2014, in Chemical & Engineering News, a weekly publication of the American Chemical Society.
The article, titled "Tug Of War Over Promising Cancer Drug Candidate," discusses how the discovery of a chemical structure error in a patented drug compound may place in jeopardy the existing patent and upcoming clinical trials.
Ken has been practicing intellectual property law for over 30 years. His primary practice specialty is counseling clients on a wide range of IP matters involving established and emerging chemical and biochemical technologies. In addition, he is frequently called upon to render patentability, validity, and infringement opinions.
IP Alert | Stock Ownership Leads to Vacatur of $2.75B District Court JudgmentAugust 8, 2022
On June 23, in Centripetal Networks v. Cisco Systems, the Federal Circuit vacated judgment of the district court because stock held by the judge's wife violated the recusal statute and was not harmless error. Read more
IP Alert | Rehearing Reverses Earlier Federal Circuit Decision Finding Silence Supported Negative Claim LimitationJuly 6, 2022
On June 21, in Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., a reshuffled Federal Circuit panel reversed course on rehearing to find that a negative claim limitation was not supported by silence in the patent's specification. Read more